| Literature DB >> 21637858 |
Wei Xue1, Radu I Cojocaru, V Joseph Dudley, Matthew Brooks, Anand Swaroop, Vijay P Sarthy.
Abstract
BACKGROUND: Ciliary neurotrophic factor (CNTF), a member of the interleukin-6 cytokine family, has been implicated in the development, differentiation and survival of retinal neurons. The mechanisms of CNTF action as well as its cellular targets in the retina are poorly understood. It has been postulated that some of the biological effects of CNTF are mediated through its action via retinal glial cells; however, molecular changes in retinal glia induced by CNTF have not been elucidated. We have, therefore, examined gene expression dynamics of purified Müller (glial) cells exposed to CNTF in vivo. METHODOLOGY/PRINCIPALEntities:
Mesh:
Substances:
Year: 2011 PMID: 21637858 PMCID: PMC3102695 DOI: 10.1371/journal.pone.0020326
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Flow-sorting Müller cells from mouse retina.
(a) Transverse section of retina from mgfap-egfp transgenic mice. Note GFP expression in radially-oriented, Müller cell processes. (b–c) Scatter plot of flow-sorted, dissociated cells from mgfap-egfp transgenic mouse retina. The cells used for RNA preparation were collected from the enclosed area in F indicated by the arrow. Dissociated cells from non-transgenic mouse retina showed no GFP-fluorescence.
List of differentially regulated genes in Müller cells one day after CNTF treatment.
| Gene Symbol | Gene Name | Fold Change | Type |
|
| Chemokine ligand 6 | 13.5 | Cytokine (19, 1) |
|
| Chemokine ligand 6 | 13.3 | - |
|
| Secreted phosphoprotein 1 | 10 | - |
|
| Tumor necrosis factor | 7.8 | - |
|
| Interleukin 1 receptor antagonist | 7.5 | - |
|
| Vav 3 guanine nucleotide exchange factor | -2.2 |
|
|
| Heme oxygenase | 15.9 | Enzyme (115, 32) |
|
| Interferon inducible GTPase 1 | 8.8 | - |
|
| Prostaglandin-endoperoxide synthase 2 | 10.3 | - |
|
| 2′-5′-oligoadenylate synthetase-like | 6.9 | - |
|
| Xanthine dehydrogenase | 6.6 | - |
|
| Platelet-activating factor acetylhydrolase 1b | -2.5 |
|
|
| RAB2B, member RAS oncogene family | -2.5 |
|
|
| RAB3C, member RAS oncogene family | -2.5 |
|
|
| Regulating synaptic membrane exocytosis 1 | -2.6 |
|
|
| Stearoyl-Coenzyme A desaturase 2 | -2.6 |
|
|
| Chemokine (C-C motif) receptor-like 2 | 12.5 | G-protein (16, 9) |
|
| G protein-coupled receptor 109A | 9.4 | - |
|
| Chemokine (C-C motif) receptor 1 | 8.9 | - |
|
| Complement component 5a receptor 1 | 7.7 | - |
|
| Egf-like module, mucin-like chemokine-like recp 1 | 7.0 | - |
|
| TM2 domain containing 1 | -2.0 |
|
|
| Xenotropic and polytropic retrovirus receptor 1 | -2.2 |
|
|
| Prostaglandin E receptor 3 (subtype EP3) | -2.7 |
|
|
| Latrophilin 3 | -2.7 |
|
|
| G protein-coupled receptor 158 | -2.9 |
|
|
| Endothelin 2 | 6.7 | Growth Factor (8, 2) |
|
| Glia maturation factor, gamma | 5.3 | - |
|
| Nudix-type motif 6 | 4.2 | - |
|
| Transforming growth factor, beta 1 | 3.8 | - |
|
| Glia maturation factor, gamma | 3.4 | - |
|
| Angiopoietin 1 | -2 |
|
|
| Fibroblast growth factor 9 (glia-activating factor) | -2 |
|
|
| Potassium channel, subfamily K, member 6 | 4.5 | Ion Channel (7, 11) |
|
| Purinergic receptor P2X, ligand-gated ion cha, 7 | 3.9 | - |
|
| Potassium channel tetramerisation domain | 3.2 | - |
|
| Potassium intermediate/small calcium-activated | 2.7 | - |
|
| Hydrogen voltage-gated channel 1 | 2.4 | - |
|
| Potassium inwardly-rectifying channel | -2.3 |
|
|
| Kv channel interacting protein 1 | -2.4 |
|
|
| Sodium channel, voltage-gated, type II, beta | -2.4 |
|
|
| Potassium large conductance calcium-activated | -2.7 |
|
|
| Syntaxin 1B | -3.1 |
|
|
| Vav 1 guanine nucleotide exchange factor | 9.7 | Transc. Regulator (78, 28) |
|
| Early growth response 2 | 8.5 | - |
|
| Activating transcription factor 3 | 7.5 | - |
|
| Kruppel-like factor 4 (gut) | 7.4 | - |
|
| Interferon, gamma-inducible protein 16 | 7.3 | - |
|
| LIM domain binding 2 | -3.3 |
|
|
| Nuclear factor I/B | -3.3 |
|
|
| Nuclear factor I/A | -3.0 |
|
|
| Cyclin T2 | -2.9 |
|
|
| Polycomb group ring finger 6 | -2.5 |
|
|
| CD14 molecule | 9.3 | Transm. Receptor (50, 3) |
|
| Interleukin 7 receptor | 8.9 | - |
|
| Macrophage scavenger receptor 1 | 8.3 | - |
|
| Toll-like receptor 2 | 8.0 | - |
|
| CD69 molecule | 7.9 | - |
|
| CD247 molecule | -2.6 |
|
|
| Glypican 6 | -2.5 |
|
|
| Interferon (alpha, beta and omega) receptor 1 | -2.1 |
|
|
| Solute carrier family 11 | 7.3 | Transporters (33,15) |
|
| Solute carrier family 15, member 3 | 5.6 | - |
|
| Solute carrier family 13 | 5.6 | - |
|
| Transporter 1, ATP-binding cassette, sub-family B | 5.4 | - |
|
| Myeloid cell leukemia sequence 1 (BCL2-related) | 5.2 | - |
|
| ATPase, H+ transporting, lysosomal 56/58kDa | -2.7 |
|
|
| SEC62 homolog | -2.7 |
|
|
| Rabphilin 3A homolog | -2.6 |
|
|
| Vacuolar protein sorting 41 homolog | -2.5 |
|
|
| Solute carrier family 6, member 1 | -2.5 |
|
The table lists the top-five up- and down-regulated genes derived from IPA analysis. The total number of up- and down–regulated genes in each type are listed along with the functional types, in column 4.
Figure 2Microarray data analysis.
(a) Hierarchical clustering showing 1261 probes that have a P-val ≤0.1 and a minimum 2-fold change between the CNTF and PBS samples at Day 1. Bright blue indicates lowest signal with increasing values indicated by yellow shading to bright red, representing peak signal. (b) Most significant 10 canonical pathways corresponding to Day 1. (c) Most significant biological functions for the same list of genes. (d) Hierarchical clustering showing 1541 probes that have a P-val ≤0.1 and a minimum 2-fold change between the CNTF and PBS samples at Day 3. (e) Most significant 10 canonical pathways corresponding to Day 3. (f) Most significant biological functions for the same list of genes.
Figure 3qRT-PCR validation of selected genes using independent biological samples.
Predicted fold changes from microarray analysis and relative gene expression fold change from qRT-PCR for 3–6 independent biological replicates of flow-sorted Müller cells. Error bars indicate ±SEM.
Canonical Pathway analysis of CNTF-induced genes at Day 1 and Day 3.
| Canonical Pathways- Day 1 | CNTF–associated genes | p-value |
| Role of Pattern RecognitionReceptors of Bacteria andViruses |
| 9.59E |
| Dendritic Cell Maturation |
| 3.06E |
| Production of Nitric Oxide and Reactive Oxygen Species in Macrophages |
| 1.93E |
| IL-10 Signaling |
| 4.67E |
| Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatiod Arthritis |
| 6.21E |
The top-five pathways and associated genes are presented.
List of differentially regulated genes in Müller cells three days after CNTF treatment.
| Gene Symbol | Gene Name | Fold Change | Type |
|
| Secreted phosphoprotein 1 | 15.8 | Cytokines (16, 4) |
|
| Chemokine (C-C motif) ligand 3-like 3 | 14.8 | - |
|
| Platelet factor 4 | 12.4 | - |
|
| Nicotinamide phosphoribosyltransferase | 4.0 | - |
|
| Chemokine (C-C motif) ligand 13 | 3.9 | - |
|
| Thrombopoietin | -2.0 |
|
|
| Prolactin | -2.1 |
|
|
| Interferon, kappa | -2.1 |
|
|
| Interleukin 1 family, member 8 (eta) | -2.3 |
|
|
| Cytochrome b-245, beta polypeptide | 14.9 | Enzymes (271, 28) |
|
| Glycoprotein (transmembrane) nmb | 14.0 | - |
|
| Glycine amidinotransferase | 11.2 | - |
|
| Peptidylprolyl isomerase B (cyclophilin B) | 10.0 | - |
|
| Hematopoietic prostaglandin D synthase | 10.0 | - |
|
| Fucosyltransferase 1 | -2.5 |
|
|
| Butyrylcholinesterase | -2.5 |
|
|
| Beta-1,3-glucuronyltransferase 2 | -2.6 |
|
|
| Guanine nucleotide binding protein, gamma 13 | -3.6 |
|
|
| Glycine cleavage system protein H | -4.7 |
|
|
| Complement component 3a receptor 1 | 20.4 | G-proteins (14, 82) |
|
| Egf-like module containing, mucin-like | 9.2 | - |
|
| Chemokine (C-X-C motif) receptor 4 | 8.1 | - |
|
| Chemokine (C-C motif) receptor 5 | 6.5 | - |
|
| G protein-coupled receptor 65 | 5.8 | - |
|
| Olfactory receptor 703 | -3.4 |
|
|
| Olfactory receptor 619 | -3.5 |
|
|
| Olfactory receptor 921 | -3.9 |
|
|
| Olfactory receptor 777 | -4.2 |
|
|
| Olfactory receptor 153 | -4.8 |
|
|
| Granulin | 5.2 | Growth Factors (3, 0) |
|
| Glia maturation factor, beta | 3.2 | - |
|
| Hepatocyte growth factor (hepapoietin A) | 2.8 | - |
|
| Chloride intracellular channel 1 | 2.7 | Ion Channels (6, 0) |
|
| Chloride intracellular channel 4 | 2.6 | - |
|
| FXYD domain containing ion transport regul 5 | 2.6 | - |
|
| Purinergic receptor P2X, ligand-gated ion chan, 4 | 2.2 | - |
|
| Purinergic receptor P2X, ligand-gated ion chan, 7 | 2.0 | - |
|
| TAF9 RNA polymerase II, TATA box binding protein | 8.1 | Transc. Reg. (80, 20) |
|
| Protein SP100 nuclear antigen | 7.3 | - |
|
| Transcription elongation factor A (SII), 1 | 7.1 | - |
|
| Suppressor of Ty 4 homolog 1 (S. cerevisiae) | 5.7 | - |
|
| V-rel reticuloendotheliosis viral oncogene homolog | 5.6 | - |
|
| Prohibitin | -2.3 |
|
|
| GLI family zinc finger 3 | -2.3 |
|
|
| V-ets erythroblastosis virus E26 oncogene homolog | -2.4 |
|
|
| Actin-binding Rho activating protein | -2.4 |
|
|
| Ankyrin repeat and zinc finger domain | -2.5 |
|
|
| Major histocompatibility complex, class I, C | 17.0 | Transm. Receptors (48, 1) |
|
| Macrophage scavenger receptor 1 | 12.9 | - |
|
| C-type lectin domain family 7, member A | 10.2 | - |
|
| Fc receptor-like 2 | 7.1 | - |
|
| Toll-like receptor 7 | 6.9 | - |
|
| GDNF family receptor alpha 2 | -2.0 |
|
|
| Serum amyloid A1 | 15.4 | Transporters (101, 11) |
|
| Mannose-6-phosphate receptor (cation dependent) | 6.3 | - |
|
| GABA(A) receptor-associated protein | 5.9 | - |
|
| Major facilitator superfamily domain containing 1 | 5.7 | - |
|
| ATPase, H+ transporting, lysosomal 31kDa, V1, E1 | 5.4 | - |
|
| Translocase of inner mitochondrial membrane 9 | -2.3 |
|
|
| ATPase, H+ transporting, lysosomal protein 2 | 2.3 |
|
|
| Insulin-like growth factor binding protein 7 | -2.5 |
|
|
| Apolipoprotein D | -2.9 |
|
|
| Dispatched homolog | -3.9 |
|
The table lists the top-five up- and down-regulated genes derived from IPA analysis. The total number of up- and down –regulated genes in each type is listed along with the functional types, in column 4.
Figure 4Changes in pathways and processes induced by CNTF.
The diagram indicates potential biological processes and their inter-relationships in Müller cells at day 1 and day 3 after CNTF treatment. The processes and pathways were generated from IPA analysis.
Figure 5The most prominently affected gene networks generated by Ingenuity Pathway Analysis.
(a) Day 1- Genes in this network are responsible for cellular development, connective tissue disorder and metabolic disease. (b) Day 3- Genes in this network are responsible for cellular function and maintenance, molecular transport and inflammatory response. Red color indicates induction, while green represents repression; color intensity correlates with fold change.
Comparison of transcript level changes in retinas from procadherin-knockout (proCAD) and light damaged mice with Müller cells from CNTF-treated mouse retinas.
| Fold Change | ||||
| Gene name | Gene symbol | proCADmutant | Lightdamage | CNTF-treated |
| CCAT enhancer binding protein |
| 5.7 | 19.3 | 4.26 |
| Ceruloplasmin |
| 0 | 8.2 | 2.43 |
| Endothelin 2 |
| 11.4 | 12.9 | 6.71 |
| GFAP |
| 5 | 3.8 | 5.41 |
| Lipocalin 2 |
| 0 | 17.9 | 2.63 |
| Oncostatin M receptor |
| 3.4 | 8.2 | 3.5 |
| S100 protein |
| 0 | 5.5 | 3.51 |
| Serpin a3n |
| 2.1 | 5.7 | 5.02 |
| SOCS-3 |
| 2.9 | 13.5 | 3.6 |
| Soluble galactose binding protein |
| 0 | 5.9 | 6.04 |
The pro-CAD and light damage data are from ref. 50.
Figure 6Overlapping genes in transcription profiles from Müller cells, astrocytes and retinal pigment epithelium (RPE).
Intensity signals for the top 2000 probes were used to generate sets of overlapping genes. The astrocyte and RPE transcriptome data are derived from published studies (56,57). Müller cell data represent signals from cells not exposed to CNTF. (a) The diagram shows that 381 transcripts were common to the three cell types, while 642 were shared between Müller cells and astrocytes, 565 between Müller cells and the RPE, and 604 between astrocytes and RPE. (b) Diagram showing overlap of transcripts among astrocytes, Muller cells and neurons. The neuron transcriptome data was obtained from a published study (56).
Figure 7Gene networks common to Müller cells, astrocytes and RPE.
(a) Most significant canonical pathways; (b) Most significant biological functions for the same list of genes; and (c) Genes in this network are responsible mitochondrial function and metabolism.